Xml Financial, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Xml Financial, LLC

  • $1.08 Billion
  • Q4 2024

A detailed history of Xml Financial, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Xml Financial, LLC holds 1,044 shares of REGN stock, worth $709,920. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,044
Previous 1,107 5.69%
Holding current value
$709,920
Previous $1.16 Million 36.11%
% of portfolio
0.07%
Previous 0.11%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
SELL
$701.85 - $1046.91 $44,216 - $65,955
-63 Reduced 5.69%
1,044 $743,000
Q3 2024

Nov 01, 2024
SELL
$1024.09 - $1201.76 $102,408 - $120,176
-100 Reduced 8.29%
1,107 $1.16 Million
Q2 2024

Jul 22, 2024
SELL
$883.2 - $1071.19 $26,496 - $32,135
-30 Reduced 2.43%
1,207 $1.27 Million
Q1 2024

May 15, 2024
SELL
$902.69 - $993.35 $18,053 - $19,867
-20 Reduced 1.59%
1,237 $1.19 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $37,208 - $42,321
48 Added 3.97%
1,257 $1.1 Million
Q3 2023

Nov 06, 2023
SELL
$692.45 - $844.37 $11,079 - $13,509
-16 Reduced 1.31%
1,209 $994,000
Q2 2023

Aug 07, 2023
BUY
$700.03 - $830.35 $42,701 - $50,651
61 Added 5.24%
1,225 $880,000
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $61,244 - $74,427
-90 Reduced 7.18%
1,164 $956,000
Q4 2022

Feb 09, 2023
SELL
$705.89 - $766.39 $21,176 - $22,991
-30 Reduced 2.34%
1,254 $904,000
Q3 2022

Nov 04, 2022
BUY
$573.97 - $724.32 $29,846 - $37,664
52 Added 4.22%
1,284 $885,000
Q2 2022

Aug 01, 2022
BUY
$548.35 - $738.84 $87,736 - $118,214
160 Added 14.93%
1,232 $728,000
Q1 2022

May 02, 2022
BUY
$595.12 - $698.43 $52,965 - $62,160
89 Added 9.05%
1,072 $749,000
Q4 2021

Feb 01, 2022
SELL
$543.48 - $670.97 $10,869 - $13,419
-20 Reduced 1.99%
983 $621,000
Q3 2021

Nov 01, 2021
BUY
$574.03 - $680.96 $60,273 - $71,500
105 Added 11.69%
1,003 $607,000
Q2 2021

Aug 10, 2021
BUY
$472.8 - $558.54 $1,418 - $1,675
3 Added 0.34%
898 $502,000
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $119,723 - $146,917
268 Added 42.74%
895 $423,000
Q4 2020

Feb 08, 2021
BUY
$478.3 - $607.98 $2,391 - $3,039
5 Added 0.8%
627 $303,000
Q3 2020

Nov 13, 2020
SELL
$544.75 - $658.21 $54,475 - $65,821
-100 Reduced 13.85%
622 $348,000
Q2 2020

Jul 31, 2020
SELL
$493.32 - $643.92 $64,624 - $84,353
-131 Reduced 15.36%
722 $450,000
Q1 2020

May 08, 2020
BUY
$336.18 - $494.43 $4,370 - $6,427
13 Added 1.55%
853 $417,000
Q4 2019

Feb 04, 2020
BUY
$274.13 - $376.51 $230,269 - $316,268
840 New
840 $315,000

Others Institutions Holding REGN

# of Institutions
1,486
Shares Held
85.6M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Xml Financial, LLC Portfolio

Follow Xml Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xml Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xml Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email